PRESS RELEASE published on 04/17/2026 at 21:00, 6 months 17 days ago Inside Information / Other news releases Innate Pharma to present interim results of IPH5201 in MATISSE Phase 2 study at AACR 2026. Study aims to enhance NSCLC treatment with anti-CD39 monoclonal antibody NSCLC Innate Pharma AACR 2026 MATISSE Phase 2 IPH5201
BRIEF published on 04/13/2026 at 07:05, 6 months 21 days ago Innate Pharma: Capital and Voting Rights Update Voting Rights Biotechnology Actions Immunotherapy Innate Pharma
BRIEF published on 04/13/2026 at 07:05, 6 months 21 days ago Innate Pharma Updates Share and Voting Rights as of April 2026 Biotechnology Shares And Voting Rights Innate Pharma April 2026 Euronext Nasdaq
PRESS RELEASE published on 04/13/2026 at 07:00, 6 months 21 days ago Inside Information / Other news releases Innate Pharma to hold its Annual General Meeting of shareholders on May 21, 2026 at 10:30 a.m. CEST in Marseille. Shareholders must register shares by May 14, 2026, 00:00 Paris time, to attend Annual General Meeting Shareholders Registration Innate Pharma Marseille
PRESS RELEASE published on 04/13/2026 at 07:00, 6 months 21 days ago Inside Information / Other news releases Innate Pharma releases total shares and voting rights as of April 9, 2026, in compliance with French regulations. Learn about its innovative immunotherapies for cancer patients Voting Rights Shares French Regulations Innate Pharma Immunothérapies
BRIEF published on 04/03/2026 at 07:05, 7 months 1 day ago Innate Pharma will participate in the Kempen Life Sciences Conference Biotechnology Conference Innate Pharma Immunothérapies Kempen Life Sciences
BRIEF published on 04/03/2026 at 07:05, 7 months 1 day ago Innate Pharma to Join Kempen Life Sciences Conference Biotechnology Investor Meetings Innate Pharma Cancer Immunotherapies Kempen Conference
PRESS RELEASE published on 04/03/2026 at 07:00, 7 months 1 day ago Inside Information / Other news releases Innate Pharma to participate in the Kempen Life Sciences Conference on April 15-16, 2026, in Amsterdam, Netherlands. The company is developing immunotherapies for cancer patients Biotechnology Innate Pharma Immunothérapies Cancer Patients Kempen Life Sciences Conference
BRIEF published on 12/11/2025 at 07:05, 10 months 24 days ago Innate Pharma Announces 2026 Financial Calendar Biotechnology Investor Information Innate Pharma Financial Schedule 2026 Key Dates
BRIEF published on 12/11/2025 at 07:05, 10 months 24 days ago Innate Pharma reveals its 2026 financial calendar Biotechnology Financial Calendar Immunotherapy Innate Pharma 2026 Results
Published on 11/04/2026 at 23:10, 6 hours 25 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 6 hours 35 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 7 hours 20 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 7 hours 30 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 04:45, 49 minutes ago Bourbon Princess Joins French Royal-Level Skincare Brand PinkPrincess for Global Debut
Published on 11/05/2026 at 04:15, 1 hour 19 minutes ago From Aba to Paris: Hearth Light Opens a New Chapter in International Intangible Cultural Heritage Exchange
Published on 11/05/2026 at 04:00, 1 hour 34 minutes ago Andamanda Phuket: A Must-Visit Water Park for Family Holiday
Published on 11/05/2026 at 03:55, 1 hour 39 minutes ago AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Published on 11/05/2026 at 03:10, 2 hours 24 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/04/2026 at 18:00, 11 hours 34 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 17:44, 11 hours 51 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Published on 11/04/2026 at 11:56, 17 hours 38 minutes ago Mersen: Number of shares and voting rights as of October 31, 2026
